Literature DB >> 30954945

Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden.

Sally F Barrington1, Michel Meignan2.   

Abstract

Increased tumor burden is associated with inferior outcomes in many lymphoma subtypes. Surrogates of tumor burden that are easy to measure, such as the maximum tumor dimension of the bulkiest lesion on CT, have been used as prognostic indices for many years. Recently, total metabolic tumor volume (MTV) and tumor lesion glycolysis have emerged as promising and robust biomarkers of outcome in various lymphomas. The median MTV and the optimal cutoffs to separate patients into risk groups in a study population are, however, highly dependent on the population characteristics and the delineation method used to outline tumor on the PET image. This issue has precluded the use of MTV for risk stratification in trials and clinical practice. Standardization of the methodology is timely to allow the potential for risk adaptation to be explored in addition to response adaptation using PET. Meetings between representatives from research groups active in the field were held under the auspices of the PET International Lymphoma and Myeloma Workshop. A summary of those discussions, which included a review of the literature and a practical assessment of methods used for outlining, including various software options, is presented. Finally, a proposal is made to perform a technical validation of MTV measurement enabling benchmark reference ranges to be derived for published delineation approaches used for outlining with various software. This process would require collation of representative imaging data sets of the most common lymphoma subtypes; agreement on pragmatic criteria for the selection of lesions; generation of a range of MTVs, with consensus to be reached on final contours in a training set; and development of automated software solutions with a set of minimum functionalities to reduce measurement variability. Methods developed in the above training exercise could then be applied to another data set, with a final set of contours and values generated. This final data set would provide a benchmark against which end-users could test their ability to measure MTVs that are consistent with expected values. The data set and automated software solutions could be shared with manufacturers with the aim of including these in standard workflows to allow standardization of MTV measurement across the world.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  lymphoma; positron emission tomography; standardization

Mesh:

Substances:

Year:  2019        PMID: 30954945      PMCID: PMC6681699          DOI: 10.2967/jnumed.119.227249

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  62 in total

1.  Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms.

Authors:  Jean-François Daisne; Mérence Sibomana; Anne Bol; Thomas Doumont; Max Lonneux; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

2.  Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Authors:  Nanda C Krak; R Boellaard; Otto S Hoekstra; Jos W R Twisk; Corneline J Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-15       Impact factor: 9.236

3.  A gradient-based method for segmenting FDG-PET images: methodology and validation.

Authors:  Xavier Geets; John A Lee; Anne Bol; Max Lonneux; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-13       Impact factor: 9.236

4.  The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.

Authors:  Janine Campbell; John F Seymour; Jane Matthews; Max Wolf; Janey Stone; Surender Juneja
Journal:  Eur J Haematol       Date:  2006-03-09       Impact factor: 2.997

Review 5.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

6.  Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance.

Authors:  P G Gobbi; M L Ghirardelli; M Solcia; G Di Giulio; F Merli; L Tavecchia; R Bertè; O Davini; A Levis; C Broglia; G C Maffè; F Ilariucci; R Dore; E Ascari
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

7.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Authors:  Ursula Nestle; Stephanie Kremp; Andrea Schaefer-Schuler; Christiane Sebastian-Welsch; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

8.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

9.  Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.

Authors:  Michael Pfreundschuh; Anthony D Ho; Eva Cavallin-Stahl; Max Wolf; Ruth Pettengell; Ingrid Vasova; Andrew Belch; Jan Walewski; Pier-Luigi Zinzani; Walter Mingrone; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Claudia Corrado; Adriana Scheliga; Markus Loeffler; Evelyn Kuhnt
Journal:  Lancet Oncol       Date:  2008-04-08       Impact factor: 41.316

10.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

View more
  25 in total

1.  Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.

Authors:  J J Eertink; C N Burggraaff; M W Heymans; U Dührsen; A Hüttmann; C Schmitz; S Müller; P J Lugtenburg; S F Barrington; N G Mikhaeel; R Carr; S Czibor; T Györke; L Ceriani; E Zucca; M Hutchings; L Kostakoglu; A Loft; S Fanti; S E Wiegers; S Pieplenbosch; R Boellaard; O S Hoekstra; J M Zijlstra; H C W de Vet
Journal:  Blood Adv       Date:  2021-05-11

2.  Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.

Authors:  Laetitia Vercellino; Roberta Di Blasi; Salim Kanoun; Benoit Tessoulin; Cedric Rossi; Maud D'Aveni-Piney; Lucie Obéric; Caroline Bodet-Milin; Pierre Bories; Pierre Olivier; Ingrid Lafon; Alina Berriolo-Riedinger; Eugenio Galli; Sophie Bernard; Marie-Thérèse Rubio; Celine Bossard; Veronique Meignin; Pascal Merlet; Pierre Feugier; Steven Le Gouill; Loic Ysebaert; Olivier Casasnovas; Michel Meignan; Sylvie Chevret; Catherine Thieblemont
Journal:  Blood Adv       Date:  2020-11-24

Review 3.  Follicular lymphoma: is there an optimal way to define risk?

Authors:  Carla Casulo
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).

Authors:  Navid Hasani; Sriram S Paravastu; Faraz Farhadi; Fereshteh Yousefirizi; Michael A Morris; Arman Rahmim; Mark Roschewski; Ronald M Summers; Babak Saboury
Journal:  PET Clin       Date:  2022-01

5.  Prognostic role of metabolic parameters (MTV and TLG) of staging PET/CT in the pediatric population with Hodgkin's lymphoma: an open discussion.

Authors:  Sara Pacella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-12       Impact factor: 10.057

6.  Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.

Authors:  Paul Blanc-Durand; Simon Jégou; Salim Kanoun; Alina Berriolo-Riedinger; Caroline Bodet-Milin; Françoise Kraeber-Bodéré; Thomas Carlier; Steven Le Gouill; René-Olivier Casasnovas; Michel Meignan; Emmanuel Itti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-24       Impact factor: 9.236

7.  SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.

Authors:  Luca Ceriani; Giuseppe Gritti; Luciano Cascione; Maria Cristina Pirosa; Angela Polino; Teresa Ruberto; Anastasios Stathis; Andrea Bruno; Alden A Moccia; Luca Giovanella; Stefanie Hayoz; Sämi Schär; Stefan Dirnhofer; Alessandro Rambaldi; Giovanni Martinelli; Christoph Mamot; Emanuele Zucca
Journal:  Blood Adv       Date:  2020-03-24

8.  High total metabolic tumor volume at baseline predicts survival independent of response to therapy.

Authors:  Laetitia Vercellino; Anne-Segolene Cottereau; Olivier Casasnovas; Hervé Tilly; Pierre Feugier; Loic Chartier; Christophe Fruchart; Louise Roulin; Lucie Oberic; Gian Matteo Pica; Vincent Ribrag; Julie Abraham; Marc Simon; Hugo Gonzalez; Reda Bouabdallah; Olivier Fitoussi; Catherine Sebban; Armando López-Guillermo; Laurence Sanhes; Franck Morschhauser; Judith Trotman; Bernadette Corront; Bachra Choufi; Sylvia Snauwaert; Pascal Godmer; Josette Briere; Gilles Salles; Philippe Gaulard; Michel Meignan; Catherine Thieblemont
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

Review 9.  A picture is worth a thousand words: a history of diagnostic imaging for lymphoma.

Authors:  N Ari Wijetunga; Brandon Stuart Imber; James F Caravelli; N George Mikhaeel; Joachim Yahalom
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

10.  Convolutional Neural Networks for Automated PET/CT Detection of Diseased Lymph Node Burden in Patients with Lymphoma.

Authors:  Amy J Weisman; Minnie W Kieler; Scott B Perlman; Martin Hutchings; Robert Jeraj; Lale Kostakoglu; Tyler J Bradshaw
Journal:  Radiol Artif Intell       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.